AL
Align Technology
ALGN · NASDAQ
$158.64 +0.49% (+$0.78)
1M -8.65%
Market Cap $11.4B
P/E Ratio 27.68x
Div. Yield -
ROE 10.09%
Bulios Fair Price
$113.38
28.5% downside
Current Price
$158.64
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALGN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
62 /100
Fair P/B 2.70x
P/S 2.77x
P/E 27.68x
Growth
55 /100
Stable Book val. growth 3.98%
FCF growth 21.03%
EPS growth 7.02%
Profitability
80 /100
Strong FCF margin 18.26%
Op. margin 13.33%
Gross margin 66.48%
Quality
51 /100
Average Asset turnover 0.65x
ROA 6.44%
ROIC 8.83%
Debt
95 /100
Low Net debt/EBITDA -1.25x
Int. coverage 401.93x
Debt/Equity 0.03x
Stability
80 /100
Stable Profitable years 6
EPS volatility 15.93%
Beta 1.65x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALGN
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Hogan
Employees
20,435
Headquarters
Tempe
Upcoming events
28 OCT
Earnings
Upcoming earnings report